UPDATE 2-AbbVie says strong results lessen need for big deal

Oct 31 (Reuters) - AbbVie, which this month abandoned its planned $55 billion purchase of Dublin drugmaker Shire, reported impressive quarterly earnings on demand for its Humira arthritis drug and...

from Reuters: Mergers News http://ift.tt/108mNO8